This article is more than 5 years old. Information may no longer be current.

Regeneron quarterly revenues increase

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Regeneron reported total revenues of $1.663 billion in the third quarter of 2018, an increase of 11% from 2017’s third quarter revenues of $1.501 billion, according to a press release.

Quarterly net income was $595 million, or $5.50 per basic share, compared with $388 million, or $3.64 per basic share, in 2017.

Research and development costs increased from $530 million to $557 million for the quarter. Selling, general and administrative expenses grew from $307 million in 2017’s third quarter to $369 million this year.